Olopatadine hydrochloride and Cimzia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Olopatadine hydrochloride (olopatadine hydrochloride) and Cimzia (certolizumab pegol). Common drug interactions include arthralgia among females.

The phase IV clinical study analyzes what interactions people have when they take Olopatadine hydrochloride and Cimzia. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Olopatadine hydrochloride?

Olopatadine hydrochloride has active ingredients of olopatadine hydrochloride. eHealthMe is studying from 4,420 Olopatadine hydrochloride users. Check the latest studies of Olopatadine hydrochloride.

What is Cimzia?

Cimzia has active ingredients of certolizumab pegol. It is often used in rheumatoid arthritis. eHealthMe is studying from 106,745 Cimzia users. Check the latest studies of Cimzia.

On Jul, 09, 2026

27 people who take Olopatadine hydrochloride and Cimzia together, and have interactions are studied.

Olopatadine hydrochloride and Cimzia drug interactions.

What are the common drug interactions of Olopatadine Hydrochloride and Cimzia, by gender? *:

female:

Arthralgia (joint pain)
Conjunctivitis (pink eye)
Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
Malaise (a feeling of general discomfort or uneasiness)
Psoriasis (immune-mediated disease that affects the skin)
Urticaria (rash of round, red welts on the skin that itch intensely)
Hypersensitivity
Hypertension (high blood pressure)
Influenza
Injury

male:

n/a

What are the common drug interactions of Olopatadine Hydrochloride and Cimzia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Fungal infection
Headache (pain in head)
Infection
Infusion site erythema (reddening of the skin at infusion site)
Infusion site pruritus (severe itching at infusion site)
Infusion site swelling
Injection site bruising
Injection site discharge
Injection site pruritus (severe itching at injection site)
Injection site swelling

30-39:

Pneumonia

40-49:

n/a

50-59:

Conjunctivitis (pink eye)
Fatigue (feeling of tiredness)
Arthralgia (joint pain)
Drug ineffective
Joint swelling
Viral infection

60+:

Dermal cyst
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Malaise (a feeling of general discomfort or uneasiness)
Dizziness
Pruritus (severe itching of the skin)
Sneezing
Arthralgia (joint pain)
Blood cholesterol increased
Injection site pain
Joint swelling

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 18.52%
Sleep Disorder: 3 people, 11.11%
Sinusitis (inflammation of sinus): 3 people, 11.11%
Pain: 3 people, 11.11%
Hypersensitivity: 3 people, 11.11%
High Blood Pressure: 3 people, 11.11%
Depression: 3 people, 11.11%
Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 3 people, 11.11%
Blood Calcium Decreased: 3 people, 11.11%
Back Pain: 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Olopatadine hydrochloride and Cimzia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously